Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy
Open Access
- 30 June 1994
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 330 (26), 1841-1845
- https://doi.org/10.1056/nejm199406303302601
Abstract
There has been no new effective drug therapy for patients with severe ulcerative colitis since corticosteroids were introduced almost 40 years ago. In an uncontrolled study, 80 percent of 32 patients with active ulcerative colitis refractory to corticosteroid therapy had a response to cyclosporine therapy.Keywords
This publication has 15 references indexed in Scilit:
- Cyclosporine Treatment of Inflammatory Bowel DiseaseMayo Clinic Proceedings, 1992
- Measurement of Colonic Tissue Cyclosporine Concentration in Children with Severe Ulcerative ColitisJournal of Pediatric Gastroenterology and Nutrition, 1992
- The Pharmacokinetics and Colonic Tissue Concentrations of Cyclosporine After IV, Oral, and Enema AdministrationThe Journal of Clinical Pharmacology, 1991
- Preliminary report: cyclosporin in treatment of severe active ulcerative colitisThe Lancet, 1990
- The risk of neoplasms in patients treated with cyclosporine AJournal of Autoimmunity, 1989
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- INTENSIVE INTRAVENOUS REGIMEN FOR SEVERE ATTACKS OF ULCERATIVE COLITISThe Lancet, 1974
- The course and prognosis of ulcerative colitis: Part I Short-term prognosisGut, 1963
- Crohn's Disease (Regional Enteritis) of the Large Intestine and its Distinction from Ulcerative ColitisGut, 1960